1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
"EIT Health funding opportunities (Call for proposals to support high-potential European SMEs)" is currently closed and not accepting applications.
EIT Health funding opportunities (Call for proposals to support high-potential European SMEs) is sponsored by European Institute of Innovation and Technology (EIT Health). This call supports high-potential European micro, small, and medium-sized enterprises (SMEs) developing innovative healthcare solutions, including in AI. The funding aims to advance product development, refine commercialization strategies, and prepare for fundraising.
Get alerted about grants like this
Get emailed when new opportunities from “European Institute of Innovation and Technology (EIT Health)” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
New call opportunities - EIT Health Get Involved New call opportunities Find New Funding and Support Opportunities Access tailored funding to design and deliver entrepreneurship programmes, support high-potential start-ups, and strengthen Europe’s health innovation ecosystem. These calls help ventures grow, scale, and reach the market faster. Access funding to support collaborative innovation projects across Europe.
These calls are designed for consortia bringing together industry, academia, healthcare providers, and other key stakeholders to develop, validate, and scale impactful healthcare solutions. Current funding and support opportunities Join our expert pool to assess EU funding applications, monitor projects, and advise on health innovation, digital health, and medical technologies.
Transformative Healthcare Instrument Access funding to accelerate the development and commercialisation of high-potential biotech, medtech, digital health and AI innovations. Access funding to accelerate market adoption and scale-up of clinically validated digital, data and AI-driven healthcare solutions. Biotech Innovation Path Call Access funding to create a new EIT Label-certified Biotech learning pathway.
Entrepreneurship & Innovation Micro-Credentials Call Access funding to develop a new EIT Label-certified micro-credentials programme in healthcare entrepreneurship and innovation. Innovation Validation Call 2026 Access funding to accelerate clinical validation, regulatory approval, and market launch for late-stage digital, data and AI-driven healthcare innovations.
New Models to Deliver Healthcare Call Access funding for market-ready health solutions to drive real-world adoption and scale value-based healthcare models across health systems.
According to the current listing, eligibility includes: Applying companies must employ at least four full-time equivalent workers and have closed a minimum total equity investment of €2,000,000 within the previous 36 months, including participation from at least one new inve…. Confirm the full requirements in the official notice before applying.
The current listing shows between €300,000 and €500,000. Verify award ceilings, matching requirements, and allowable costs in the official notice.
The published deadline was June 26, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
EIT Health funding opportunities (Call for proposals to support high-potential European SMEs) is funded by European Institute of Innovation and Technology (EIT Health). Verify program details on the funder's official page before applying.
Applications go through the funder's official portal — the Apply Now link on this page goes there directly.
NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.
Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science (SCH) is sponsored by National Science Foundation (NSF) & National Institutes of Health (NIH). This interagency program supports high-risk, high-reward interdisciplinary projects that leverage AI, machine learning, and advanced data science to address pressing questions in biomedical and public health research. It seeks to advance fundamental scientific and engineering contributions across disciplines to solve key health problems.
Schmidt Marine Technology Partners funds the development and deployment of ocean technology — sustainable fisheries, ocean observation, habitat restoration, and pollution — with grants typically $100,000 to $400,000. The initial proposal window closes July 31, 2026. Here's what makes this funder different and how to write for it.
Read articleARPA-H's FY2026 SBIR/STTR solicitation opens with a Solution Summary due July 10, 2026, then a Technical Oral Presentation by September 9 for those invited. Awards run up to $600K (Phase I) and $3.5M (Phase II), with Direct-to-Phase-II and Fast Track options across seven health topic areas. Here is how the two-step, pitch-driven process differs from NIH SBIR — and how to win the first gate.
Read articleMTO opened six SBIR topics on May 27 with a single June 24 close: nanopore proteomics, compact wideband tunable RF filters, 800°C-rated integrated circuits, passive thermal spreaders, radiation-hardened codesign, and low-resource computing for legacy hardware reuse. Together they map the office's bet on where U.S. semiconductor advantage gets reasserted — and which small businesses get to ride along.
Read article